Key facts
- Notable investors include CAS Star.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Longzang Biology
- ·The full record, as it builds
Funding rounds
No funding rounds for Longzang Biology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Longzang Biology
Developer of plant-derived bioactive compounds designed for pharmaceutical and industrial applications.
- Sector
- Healthcare
- HQ
- Changzhou, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Longzang Biology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Longzang Biology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Longzang Biology in its N-PORT filings yet. We sweep new filings monthly.